Cancer Registry

Saint John's Tumor Board and Registry maintains detailed information on each cancer incidence, treatment and outcome.

Clinical Trials
Some patients undergoing cancer treatment at the Cancer Center are voluntarily participating in clinical trials that provide valuable information to cancer researchers.  Cancer Center patients may choose to participate in Phase 3 level clinical trials.  These trials compare two proven and effective treatment plans to see if one has an advantage over another.

Saint John's Cancer Center has participated in clinical trials through the National Institutes of Health since 1977.

Current Available Protocols
 for Patient Accrual at Saint John’s Cancer Center
October 2005

RTOG 9804 A Phase III protocol for patients with Ductal Carcinoma In-Situ Breast Comparing Arm 1 : Radiation Therapy +/- Tamoxifen versus Arm 2 : Observation +/- Tamoxifen

RTOG 0212 A Phase III protocol for patients with Small Cell Lung Cancer Administering Prophylactic Cranial Irradiation to prevent brain metastasis.

RTOG 0214 A Phase III protocol for patients with Non-Small Cell Lung cancer Administering Prophylactic Cranial Irradiation to prevent brain metastasis.

RTOG 0315 A Quality of Life Double blind Study using Sandostatin LAR for
Patients with anal/rectal cancer being treated with radiation therapy who are experiencing diarrhea.

RTOG 0433 A Phase III protocol for patients with painful bone metastasis Requiring re-irradiation to these sites. The study will be tesing one dose of radiation versus multiple smaller doses.

*** RTOG = Radiation Therapy Oncology Group
Phase III = all treatments =
 

Those interested in participating in treatment trials should discuss the options with their physicians.  For additional information about the value of clinical studies or availability, contact the Cancer Registry at 765-646-8459.